Quest Extends HPV Marketing Deal With Digene for Four More Years

Jul 27, 2007

NEW YORK (GenomeWeb News) — Digene this week said it has extended by four years a three-year agreement with Quest Diagnostics under which Quest will market Digene’s test for human papillomavirus.

Digene will continue to supply Quest’s labs with the instrumentation and reagents for HPV testing, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Closely Intertwined

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Little From Here and There

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

This Week in Science

In Science this week: in vitro generation of human reproductive cells, and more.

All the Arms for Hugging

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Main menu